Swiss and German Team to Develop Inhaled mRNA Coronavirus Treatment
The Swiss antibody specialist Neurimmune and the German RNA biotech Ethris are collaborating to develop…
The Swiss antibody specialist Neurimmune and the German RNA biotech Ethris are collaborating to develop…
The Swiss company NovaGo has raised €8.8M (CHF 10M) in Series A funding to develop…
Neurimmune and Ono Pharmaceutical have partnered to develop an antibody drug against a still undisclosed neurodegenerative…
May 5, 2017, saw the first FDA approval for an amyotrophic lateral sclerosis (ALS) drug…
Before the “who to recruit” phase, an important question is “where?” We ran through the…
AL-S Pharma was just born with the only purpose of developing a drug candidate for…
The biggest city in Switzerland, Zurich, is one of Europe's top financial centers and home…